Abstract
Neurotoxicity is the degree of toxicity produced by molecules of contrast media in contact with the central nervous system following intracisternal or intrathecal injection. Like systemic toxicity, neurotoxicity is expressed as LD50 (in g I/kg or in mmol/kg) and corresponds to the intrathecal dose inducing death in 50% of experimental animals after injection. The neurotoxicity index is defined as the ratio between intravenous LD50 and intrathecal LD50.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams MD, Hopkins RM,Ferrendelli JA (1988) A rat EEG model for evaluating contrast media neurotoxicity. Invest Radiol (Suppl 1) 23:S217–S219.
Adams MD, Ralston WH, Ferrendelli JA (1990) Electroencephalographic effects of intracisternally injected nonionic X-ray contrast media in rats. Invest Radiol 25:S86–S87.
Almén T (1989) Relations between chemical structure, animal toxicity and clinical adverse effects of contrast media. In: Enge I, Edgren J (eds) Patient safety and adverse events in contrast medium examinations. Elsevier Science, Amsterdam, p 25.
Aulie A (1980) Effect of iohexol, metrizamide and ioxaglate on the blood-brain barrier. Acta Radiol (Suppl) 362:13–16.
Avrahmi E, Weiss-Peretz J, Conn DF (1989) Epilepsy in patients with brain metastases triggered by intravenous contrast medium. Clin Radiol 40:422.
Belloni G, Bonaldi G, Monchini L (1988) Neurotossicità dei mezzi di contrasto iodati. Riv Neuroradiol 1:147–153.
Bonnemain B, Meyer D, Schaefes M, et al. (1990) New iodinated, low-osmolar contrast media. A revised concept of hydrophilicity. Invest Radiol 25:S104–S106.
Buchman AS, Klawans HL, Russell EJ (1987) Metrizamide and its neurological complications. Clin Neuropharmacol 10:1.
Caillé JM, Allard M (1983) Neurotoxicity of hydrosoluble iodine contrast media. Invest Radiol 23(Suppl 1):S210.
Caillé JM, Allard M (1988) Mezzi di contrasto in neuroradiologia. Riv Neuroradiol 1:129–138.
Carchetti E, Baldassasare M, Penco T, Heonardi M (1988) Iopamidol 300-induced epilepsy. Intensive treatment and pathogenetic hypothesis. Neuroradiology 30:256.
Castel JC, Dorcier F, Caillè JM (1987) Penetration of the brain by nonionic water soluble tri- and hexaiodinated contrast media. Experimental autoradiographic study of two contrast media: iotrol and iopamidol labelled with iodine 125. Neuroradiology 29:206–210.
Corsico N, Tirone P (1988) Mezzi di contrasto iodurati ionici e non-ionici in neuroradiologia: aspetti farmaco-tossicologici. Riv Neuroradiol 1:155–159.
Dunker RO, Harris AB, Jenkins DP (1976) Kinetics of horse¬radish peroxidase migration through cerebral cortex. Brain Res 118:199.
Elkin C, Levan AMT, Leeds NE (1986) Tolerance of iohexol, iopamidol and metrizamide in lumbar myelography. Surg Neurol 26:542.
Evill CA, Wilson AJ, Sage MR (1990) Chemotoxic effects of low-osmolar contrast media on the blood-brain barrier. Invest Radiol 25:S82–83.
Facino RM, Raffaelli E, Pitre E (1979) Iopronic acid interaction with hepatic microsomal cytochrome P-450: relationship between chemical structure and binding. Pharmacol Res Commun 11:105–113.
Floras P, Deliac P, Gross C, et al. (1990) Neurotoxicité de Plohexol vs Iopamidol dans la myélographie lombaire. Correlations clinique, électrophysiologique et tomodensitométrique. J Neuroradiol 17:190–200.
Giang DW, Kido DK (1989) Transient global amnesia associated with cerebral angiography performed with use of iopamidol. Radiology 172:195.
Hayakawa K, Yamashita K, Mitsumori M, Nakano Y (1990) Iodinated contrast media. In vivo quantification of the blood-brain barrier injury using magnetic resonance enhancement. Invest Radiol 25:S80–S81.
Higgins CB, Schmidt WS (1979) Identification and evaluation of the contribution of the chemoreflex in the hemodynamic response to intracarotid administration of contrast materials in the conscious dog: comparison with the response to nicotine. Invest Radiol 14:438–446.
Hoppe JO, Archer S (1960) X-ray contrast media for cardiovascular angiography. Angiology 11:244.
Jeppson PG, Olin T (1970) Neurotoxicity of roentgen contrast media: study of the brain-blood barrier following selective injection of contrast media into the internal carotid artery. Acta Radiol 10:17–34.
Junck L, Marshall WH (1983) Neurotoxicity of radiological contrast agents. Ann Neurol 13:469.
Juni J, Morera J, et al. (1992) Transient global amnesia after cerebral angiography with iohexol. Neuroradiology 34: 141.
Katayama H, Yamaguchi K, Kozuka T, et al. (1990) Adverse reactions to ionic and non-ionic contrast media. A report from Japanese Committee on the Safety of Contrast Media. Radiology 175:621.
La Noce A, Bertani F, Lorusso V, Luzzani F, Tirone P, De Haen C (1994) Preclinical safety assessment of iomeprol for injection as contrast medium for myelography. Eur J Radiol 18(Suppl 1):S43–S50.
La Noce A, Lorenzon P, Pugliese F, et al. (1996) Brain penetration of intrathecal iomeprol in dogs. Acta Radiol 37:578–581.
Lalli AF (1980) Contrast media reactions: data analysis and hypothesis. Radiology 134:1–12.
Lantos G (1989) Cortical blindness due to osmotic disruption of the blood-brain barrier by angiographic contrast material. CT and MRI studies. Neurology 39:567.
Larsen LE, Heglund IF, Fabian R, et al. (1995) Neural tolerability of iodixanol in mice and dogs after single and repeated intracisternal administration. Acta Radiol (1995) 36(Suppl 399):238–243.
Leonardi M, Lavaroni A, Bianizzo E, et al. (1989) High-dose contrast-enhanced computed tomography (CECT) with iopamidol in the detection of cerebral metastases. Tolerance of the contrast agent. Neuroradiology 31:148–150.
Leonardi M, Auxilia F, Cosmacini G, Ottomano C (1995) Impiego degli esami ematochimici preliminari all’iniezione di mezzo di contrasto: è possibile rinunciarvi? Riv Neuroradiol 8:323–327.
Levey AI, Weiss H, Yu R, Wang H, Krumholz A (1988) Seizures following myelography with iopamidol. Ann Neurol 23:397.
Luzzani F, Morisetti A, Bussi S, Tirone P, De Haen C (1996) Neurotolerability of nonionic X-ray contrast media. Invest Radiol 31:338–344.
Maly P, Sundgren P, Baath L, Golman K, Walday P (1995) Adverse reactions in myelography. Correlation between animal research and clinical practice. Acta Radiol 36 (Suppl 399):230–237.
Marder E, O’Neil M, Grossman RI, et al. (1983) Cholinergic actions of metrizamide. AJNR 4:61–65.
Moschini M, Manara O, Bonaldi G, Cassinari V, Quilici N, Belloni G (1983) Iopamidol and metrizamide in cervical myelography: side effects, EEG and CSF changes. AJNR 4:848–850.
Nakstad P, Helgetveit A, et al. (1984) Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double blind parallel study. Neuroradiology 26:479.
Palmer J (1990) Morbidity and mortality with intravenous contrast media ionic and nonionic. Invest Radiol 25:S18–S19.
Pullicino P, Kendall BE (1980) Contrast enhancement in ischaemic lesions: in relationship to prognosis. Neuroradiology 19:253–259.
Rapoport ST, Levitan H (1974) Neurotoxicity of x-ray contrast media: relation to lipid solubility and blood-brain barrier permeability. Am J Roentgenol 122:186–193.
Rapoport SI, Fredericks WR, Ohno K, Pettigrew KD (1980) Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol 238:R421.
Rosati G (1994) Clinical utility and safety profile of iomeprol. Eur J Radiol 18(Suppl 1):S120–S124.
Rosati G, Leto di Priolo S, Tirone P (1992) Serious or fatal complications after inadvertent administration of ionic water-soluble contrast media in myelography. Eur J Radiol 15:95–100.
Sage MR, Wilcox J, Evill CA, Benness GT (1982) Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate. Invest Radiol 17:276–281.
Sage MR, Wilcox J (1983) Brain parenchyma penetration by intrathecal nonionic iopamidol. AJNR 4:1181–1183.
Sage MR, Turski PA, Levin A (1989) CNS imaging of the brain barrier. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation. Plenum, New York, vol 2, Chap. 14.
Schmidt RC (1980) Mental disorders after myelography with metrizamide and other water soluble contrast media. Neuroradiology 19:153.
Scott WR (1980) Seizures. A reaction to contrast media for computed tomography of the brain. Radiology 137:359.
Speck U, Press WR, Mutzel W (1988) Osmolality-related effects of injections into the central nervous system. Invest Radiol 23(Suppl 1):S114–S117.
Tahta K, Ozgen T, Betker M, et al. (1993) Status epilepticus following iohexol myelography. Neuroradiology 35:322.
Thomsen S, Dorph S (1993) High-osmolar and low-osmolar contrast media. An update on frequency of adverse drug reactions. Acta Radiol 34:205.
Thomson KR, Wells DG, O’Brien K, Tomkins DC, Dixon RG (1990) Vertebral artery injections of methylglucamine diatrizoate, 60% iopromide, and iotrolan in the rabbit. Invest Radiol 25:S88–S89.
Torvik A, Wakday P (1995) Neurotoxicity of water-soluble contrast media. A review. Acta Radiol 36(Suppl 399):221–229.
Vestergaard A, Dons K, Eskesen V, et al. (1991) Central nervous system reactions to cervical myelography. Acta Radiol 32:411.
Whisson CC, Evill CA, Wilson AJ, et al. (1990) Muscular and central nervous system side effects of intracarotid contrast media in rabbits. Invest Radiol 25:S90–S91.
Wilcox J, Wilson AJ, Evill CA, Sage MR (1987) A comparison of blood-brain barrier disruption by intracarotid iohexol and iodixanol in the rabbit. AJNR 8:769–772.
Zweifler RM, Rothrock JF (1995) Aseptic meningoencephalitis following iohexol myelography. Neuroradiology 37:148–149.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Leonardi, M., Agati, R. (1999). Neurotoxicity. In: Thomsen, H.S., Muller, R.N., Mattrey, R.F. (eds) Trends in Contrast Media. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59814-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-59814-2_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64136-7
Online ISBN: 978-3-642-59814-2
eBook Packages: Springer Book Archive